BCAT1 Gene - Branched Chain Amino Acid Transaminase 1

Cytosolic enzyme involved in leucine, isoleucine, and valine metabolism; implicated in cancer and neurological disorders.

Gene Information Card

Symbol BCAT1
Full Name Branched chain amino acid transaminase 1
Gene Type Protein coding
Chromosomal Location 12p12.1
NCBI Gene ID 586 ncbi.nlm.nih.gov/gene/586
Ensembl ID ENSG00000111276
UniProt ID P54687
OMIM ID 113520
HGNC ID HGNC:977
Aliases BCT1, BCATC, MECA, PP2Calpha, dJ383J4.3

Description

BCAT1 (Branched Chain Amino Acid Transaminase 1) encodes a cytosolic enzyme that catalyzes the reversible transamination of branched-chain amino acids (leucine, isoleucine, valine) to their corresponding alpha-keto acids. This gene is highly expressed in the brain and is involved in nitrogen shuttling and glutamate metabolism. BCAT1 is frequently upregulated in glioblastoma and other cancers, where it promotes tumor growth by supporting the TCA cycle and redox balance. Mutations in BCAT1 are associated with hypervalinemia and hyperleucine-isoleucinemia.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hypervalinemia Deficiency of BCAT1 leads to accumulation of valine due to impaired transamination. OMIM #277100
Hyperleucine-isoleucinemia Loss-of-function mutations in BCAT1 cause elevated leucine and isoleucine levels. OMIM #238340
Glioblastoma BCAT1 overexpression in IDH1 wild-type glioblastoma promotes alpha-ketoglutarate production and tumor proliferation. COSMIC; PMID: 24651015
Colorectal cancer BCAT1 upregulation correlates with poor prognosis and increased branched-chain amino acid catabolism. COSMIC; PMID: 25378308

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 45.2 High
Skeletal muscle 12.8 Medium
Heart 8.5 Medium
Liver 2.1 Low
Kidney 3.4 Low
Cell Line Expression
Cell Line nTPM Notes
U87MG (glioblastoma) 78.3 Overexpressed in IDH1 wild-type lines
HEK293 (embryonic kidney) 15.6 Basal expression
HCT116 (colorectal carcinoma) 22.1 Upregulated compared to normal colon
MCF7 (breast cancer) 5.4 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense Rare Loss of start codon; likely loss of function
c.245G>A (p.Arg82Gln) Missense Rare Impaired enzyme activity; associated with hypervalinemia
c.764C>T (p.Pro255Leu) Missense Rare Reduced transaminase activity
c.1123G>A (p.Gly375Arg) Missense Rare Unknown functional effect
Mutation functional classification

Loss of Function (LOF)

Mutations such as p.Arg82Gln and p.Pro255Leu reduce or abolish transaminase activity, leading to branched-chain amino acid accumulation.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in BCAT1.

Dominant Negative (DN)

No dominant-negative mutations described for BCAT1.

Pathways

Branched-chain amino acid degradation (Reactome: R-HSA-70895)
Valine
leucine and isoleucine degradation (KEGG: hsa00280)
Glutamate metabolism (Reactome: R-HSA-210500)

Protein Summary

BCAT1 is a 386-amino acid cytosolic protein (UniProt P54687) that functions as a homodimer. It catalyzes the first step in branched-chain amino acid catabolism, transferring the amino group to alpha-ketoglutarate to form glutamate. The enzyme is highly expressed in brain and muscle, and its dysregulation is linked to cancer metabolism, particularly in glioblastoma where it supports the TCA cycle via alpha-ketoglutarate production.

Related Products

Product name Cat.No. Species Gene ID
BCAT1 Knockout HEK293 Cell Line EDJ-KQ3038 Human 586 Details Get a Quote
BCAT1 Knockout A-549 Cell Line EDJ-KQ24271 Human 586 Details Get a Quote
BCAT1 Knockout HeLa Cell Line EDJ-KQ24272 Human 586 Details Get a Quote
BCAT1 Knockout Hep-G2 Cell Line EDJ-KZ115 Human 586 Details Get a Quote
BCAT1 Knockout Huh-7 Cell Line EDJ-KZ116 Human 586 Details Get a Quote
BCAT1 Knockout HCT 116 Cell Line EDJ-KQ69670 Human 586 Details Get a Quote
Displaying Records 1 To 6 Of 6 Records
Contact Us
*
*
*
*
How did you hear about us: